| Theodore E Mollerud, | |
|
2215 E Clairemont Ave, Suite 2, Eau Claire, WI 54701-4772 | |
| (715) 831-0289 | |
| (715) 831-4722 |
| Full Name | Theodore E Mollerud |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 2215 E Clairemont Ave, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770539827 | NPI | - | NPPES |
| 42813100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 30-156 (Wisconsin) | Primary |
| Provider Name | Everclear Hearing Products |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073991543 PECOS PAC ID: 4385911908 Enrollment ID: O20170601001174 |
News Archive
The governor's inability to stand up to pressure from his own party will slow progress. The rejected grant was also helping to fund information technology intended to make the state's Medicaid eligibility process more efficient and cost effective. Now that project also may be jeopardized (8/11).
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
Women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospitals with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.
Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.
Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theodore E Mollerud, 2215 E Clairemont Ave, Suite 2, Eau Claire, WI 54701-4772 Ph: (715) 831-0289 | Theodore E Mollerud, 2215 E Clairemont Ave, Suite 2, Eau Claire, WI 54701-4772 Ph: (715) 831-0289 |
News Archive
The governor's inability to stand up to pressure from his own party will slow progress. The rejected grant was also helping to fund information technology intended to make the state's Medicaid eligibility process more efficient and cost effective. Now that project also may be jeopardized (8/11).
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
Women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospitals with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.
Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.
Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.
› Verified 3 days ago
Michele Suzanne Elkin, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 900 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-717-4121 Fax: 715-717-1480 | |
Karen A Anderson, AUDIOLOGIST Audiologist Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Nicole Stephanie Smith, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2215 E Clairemont Ave, Suite 2, Eau Claire, WI 54701 Phone: 715-831-0289 Fax: 715-831-4722 | |
Rebecca A Bredl, AUD CCCA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2116 Craig Road, Eau Claire, WI 54701 Phone: 715-858-4747 | |
Amanda Rose Burg, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 | |
Ashley Kathleen Lester Emmer, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Shawna Sue Lee, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 900 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-717-6885 Fax: 175-717-6886 |